Kaya Holdings (KAYS) FCF Margin (2014 - 2025)
Kaya Holdings (KAYS) recorded quarterly FCF Margin of 1252.03% in Q3 2025, up 39.33% quarter-over-quarter from 2063.8% in Q2 2025, and down 7777.0% on a YoY basis from 16.31% in Q3 2024.
Kaya Holdings (KAYS) FCF Margin (2014 - 2025) Analysis & Trends
Kaya Holdings' FCF Margin history runs 12 years deep, the most recent figure standing at 1252.03% for Q3 2025.
- In Q3 2025, FCF Margin fell 7777.0% year-over-year to 1252.03%; the TTM figure through Sep 2025 stood at 60281.64% (up 6156150.0% YoY), while the FY2024 annual figure was 12026.32%, down 1142398.0% from the prior year.
- FCF Margin was 1252.03% for Q3 2025 at Kaya Holdings, up from 2063.8% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1402.5% in Q4 2024 to a low of 2603.15% in Q1 2025.
- Historically, FCF Margin has averaged 555.7% across 5 years, with a median of 274.49% in 2022.
- The sharpest annual moves came in 2024 and 2025: FCF Margin soared 236553 bps in 2024, then slumped 218023 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 258.89% in 2021, then rose by 29 bps to 183.53% in 2022, then plunged by 425 bps to 963.04% in 2023, then soared by 246 bps to 1402.5% in 2024, then slumped by 189 bps to 1252.03% in 2025.
- The last three FCF Margin figures came in at 1252.03% (Q3 2025), 2063.8% (Q2 2025), and 2603.15% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -429.96% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 32.62% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 13.24% |
| 10 | Kaya Holdings | - | - | 5,370.00 | -1,252.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,252.03% |
| Jun 30, 2025 | -2,063.80% |
| Mar 31, 2025 | -2,603.15% |
| Dec 31, 2024 | 1,402.50% |
| Sep 30, 2024 | -1,174.27% |
| Mar 31, 2024 | -422.92% |
| Dec 31, 2023 | -963.04% |
| Sep 30, 2023 | -287.97% |
| Jun 30, 2023 | -679.08% |
| Mar 31, 2023 | -645.60% |
| Dec 31, 2022 | -183.53% |
| Sep 30, 2022 | -100.24% |
| Jun 30, 2022 | -261.02% |
| Mar 31, 2022 | -191.68% |
| Dec 31, 2021 | -258.89% |
| Sep 30, 2021 | -82.28% |
| Jun 30, 2021 | -146.55% |
| Mar 31, 2021 | -89.12% |
| Dec 31, 2020 | 5.77% |
| Sep 30, 2020 | -32.87% |